which disrupt insulin release. Sulfonylureas close these channels and restore insulin release, and have been successfully used to replace insulin treatment for patients with Kir6.2 mutations.

Background: A 12-week-old female presented with neonatal diabetes. Insulin therapy alleviated the diabetes, but the patient showed marked motor and mental developmental delay. The patient ...

Among 18,851 patients who ever used metformin, 15,786 (83.7%) used it as their only first diabetes medication. In contrast, sulfonylurea and insulin were often used as second- or third-line ...

Many people with type 2 diabetes can manage their blood sugar levels with lifestyle changes, including exercise and nutrition ...

Diabetes and heart health are closely connected. People with diabetes have a higher risk of heart failure, a condition where ...

Those were called sulfonylureas, the drugs that stimulate the pancreas to make more insulin. Now we have, in addition to that, drugs that improve insulin sensitivity in muscle and fat, so called ...

The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmac ...